Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland

Alcohol and Alcoholism

Volumn 42, Issue 4, 2007, Pages 333-339

  Buri, Caroline ^a   Moggi, Franz ^a   Giovanoli, Anna ^a   Strik, Werner ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; DISULFIRAM; NALTREXONE;

ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; RESIDENTIAL CARE; SWITZERLAND; TIME;

ADULT; AGE FACTORS; ALCOHOL DETERRENTS; ALCOHOLISM; DISULFIRAM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INPATIENTS; MALE; MENTAL DISORDERS; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PRESCRIPTIONS, DRUG; PSYCHOLOGICAL TESTS; RECURRENCE; SUBSTANCE-RELATED DISORDERS; SWITZERLAND; TAURINE; TREATMENT OUTCOME;

EID: 37449028282     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agm038     Document Type: Article

References (33)

1. Annis, H. M. and Davis, C. S. (1988) Self-efficacy and the prevention of alcoholic relapse. Initial findings from a treatment trial. In Addictive Disorders: Psychological Research on Assessment and Treatment Baker, T. B., Cannon, D. eds. Praeger, New York.
2. Anton, R., O'Malley, S., Ciraulo, D. A. et al. (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: A randomized controlled trial. Journal of the American Medical Association 295, 2003-2017.
3. Berglund, M. (2005) A better widget? Three lessons for improving addiction treatment from a meta-analytical study. Addiction 100 742-750.
4. Berglund, M., Thelander, S., Salaspuro, M. et al. (2003) Treatment of alcohol abuse: An evidence-based review. Alcoholism-Clinical and Experimental Research 27, 1645-1656.
5. Bühringer, G. (2006) Allocating treatment options to patient profiles: Clinical art or science? Addiction 101, 646-652.
6. Cohen, J. (1988) Statistical Power Analysis for Behavioral Sciences Lawrence Erlbaum, Hillsdale, NJ.
7. Del Boca, F. K. and Darkes, J. (2003) The validity of self-report of alcohol consumption: State of the science and challenges for research. Addiction 98, 1-12.
8. Derogatis, L. R. (1993) Brief Symptom Inventory. National Computer Systems, Minneapolis, MN.
9. Dilling, H., Mombour, W. and Schmidt, M. H. (1991) In Internationale Klassifikation Psychischer Störungen, ICD-10 Kapitel, V. ed. Klinisch-diagnostische Leitlinien, Huber, Bern.
10. Ehrenreich, H., Mangolz, A., Schmitt, M. et al. (1997) OLITA - an alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approach. European Archives of Psychiatry and Clinical Neuroscience 247, 51-54.
11. Feeney, G. F. X., Connor, J. P., Young, R. M. et al. (2006) Combined acamprosate and naltrexone, with cognitive behavioral therapy, is superior to either medication alone for alcohol abstinence: A single center's experience with pharmacotherapy. Alcohol and Alcoholism 41, 321-327.
12. Franke, G. H. (2000) BSI. Brief Symptom Inventory von L.R. Derogatis - Deutsches Manual [BSI. Brief Symptom Inventory by L.R. Derogatis - German Manual]. Beltz, Göttingen.
13. Fuller, R. K. and Gordis, E. (2004) Does disulfiram have a role in alcoholism treatment today? Addiction 99, 21-24.
14. Hasselblad, V. and Hedges, L. V. (1995) Meta-analysis of screening and diagnostic tests. Psychological Bulletin 117, 167-178.
15. Heinz, A., Löber, S., Georg, A. et al. (2003) Reward craving and withdrawal relief craving: Assessment of different motivational pathways to alcohol intake. Alcohol and Alcoholism 38, 35-39.
16. Hubbard, R. L., Marsden, M. E., Cavanaugh, J. V. and Ginzburg, H. M. (1989) Drug and Abuse Treatment. A National Study of Effectiveness University of North Carolina Press, Chapel Hill, NC.
17. Humphreys, K. and Weisner, C. (2000) Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. American Journal of Psychiatry 157, 588-594.
18. Kiefer, F., Jahn, H., Tarnaske, T. et al. (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism. Archives of General Psychiatry 60, 92-99.
19. Mann, K. (2004) Pharmacotherapy of alcohol dependence. A review of the clinical data. CNS Drugs 18, 485-504.
20. Mann, K., Lehert, P. and Morgan, M. Y. (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: Results of a meta-analysis. Alcoholism-Clinical and Experimental Research 28, 51-63.
21. Maude-Griffin, P. M., Finney, J. W. and Moos, R. H. (1992) Multi-Site Evaluation of VA Inpatient Substance Abuse Treatment. Measures and Conceptual Domains. Program Evaluation and Resource Center and HSR&D Center for Health Care Evaluation VA. Palo Alto Health Care System, Palo Alto, CA.
22. Miller, W. R. (2004) Combined Behavioral Intervention Manual. A Clinical Research Guide for Therapists Treating People with Alcohol Abuse and Dependence, Vol. 1. National Institute on Alcohol Abuse and Alcoholism (NIAAA), Bethesda, MD.
23. Miller, W. R. and Tonigan, J. S. (1996) Assessing drinkers' motivation for change. The stages of change readiness and treatment eagerness scale (SOCRATES). Psychology of Addictive Behaviors 10, 81-89.
24. Miller, W. R. and Wilbourne, P. L. (2002) Mesa Grande: A methodological analysis of clinical trials of treatment for alcohol use disorders. Addiction 97, 265-277.
25. Moggi, F., Giovanoli, A., Strik, W. et al. (2007) Substance use disorder treatment programs in Switzerland and USA: Program characteristics and one-year outcomes. Drug and Alcohol Dependence 86, 75-83.
26. Moos, R. H., Cronkite, R. C. and Finney, J. W. (1990a) Health and Daily Living form Manual. Mind Garden, Palo Alto, CA.
27. Moos, R. H., Finney, J. W. and Cronkite, R. C. (1990b) Alcoholism Treatmeht. Context, Process, and Outcome. Oxford University Press, New York.
28. Ogborne, A. C. (1995) Social factors influencing the outcome of alcoholism treatment: Implication for treatment evaluation. Alcoholism 31, 59-67.
29. Petrakis, I. L., Poling, J., Levinson, C. et al. (2005) Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biological Psychiatry 57, 1128-1137.
30. Pettinati, H. M., Weiss, R. D., Miller, W. R. et al. (2004) Medical Management Treatment Manual. A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as a Part of Treatment for Alcohol Dependence, Vol. 2. National Institute on Alcohol Abuse and Alcoholism (NIAAA), Bethesda, MD.
31. Roozen, H. G., de Waart, R., van der Windt, D. A. W. M. et al. (2006) A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. European Neuropsychopharmacology 16, 311-323 [Dec. 14; Epub ahead of print].
32. Schindler, C., Körkel, J., Grobe, G. and Stern, M. (1997) Testtheoretische Güte des "Kurzfragebogens zur Abstinenzzuversicht" (KAZ-35): Validität und Reliabilität. Sucht 43, 319-328.
33. Seligman, M. E. P. (1995) The effectiveness of psychotherapy. The Consumer Reports Study. American Psychologist 50, 965-974.